Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Matthew Wikler currently holds 290,472 shares of Matinas BioPharma Holdings, Inc. (MTNB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Matthew Wikler has been a net neutral trader of MTNB stock. They have purchased $0 and sold $0 worth of shares.
Matthew Wikler's most recent insider trade was on Dec 31, 2021, when they sold 7,859 shares at $0.00 per share.
Matthew Wikler serves as Executive at Matinas BioPharma Holdings, Inc. (MTNB). They have executed 20 insider transactions totaling $0 over their tenure at the company.
Matthew Wikler holds the position of Executive at Matinas BioPharma Holdings, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Matthew Wikler has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Matthew Wikler was on Dec 31, 2021, when they purchased $0 worth of MTNB shares. This transaction involved 7,859 shares at N/A per share.
Matthew Wikler currently owns 290,472 shares of Matinas BioPharma Holdings, Inc. (MTNB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Matthew Wikler's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Matthew Wikler has 20 Form 4 filings on record as an insider at Matinas BioPharma Holdings, Inc..
Set alerts for Matthew Wikler and 40,000+ other insiders.